ELIZABETH FRICKE: Open Payments
NPI 1366106486 · ROYAL PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 21 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $683 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Lilly USA, LLC | 3 | $48 |
| Novo Nordisk Inc | 2 | $43 |
| ABBVIE INC. | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| Gilead Sciences, Inc. | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: MOUNJARO, Ozempic, LEQVIO, LINZESS, OTEZLA, NEXLETOL, ENTRESTO, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
